University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Vinorelbine injection

For hospital use only

Status: Green Viscotears eye drops

Liquid gel. Single dose units. High relative cost.

Status: Red Vismodegib

Commissioning to be confirmed prior to initiation

Status: Amber Vitamin and mineral supplements (Ketovite)

Tablets and liquid.

Status: Green Vitamin B compound strong tablets

Do not use with vitamin B compound tablets.

Status: Amber Vitamins A and D capsules

Specialist recommendation.

Status: Amber Vortioxetine (Brintellix)

Specialist initiation only and RICaD

Status: Amber Warfarin tablets

First choice. BSSE APC preferred agent. This recommendation must only be taken into account after a patient and prescriber have discussed all treatment options (including warfarin) and only if they have no preference about which medicine they want to use. To be initiated by those who have the appropriate skills and experience.

Use should be in line with local commissioning arrangements - for BCC CCG - Anticoagulation AQP. Ensure that patients prescribed anticoagulants receive appropriate verbal and written information at the start of therapy, at hospital discharge, on the first anticoagulant clinic appointment, and when necessary throughout the course of their treatment (NPSA Alert 18)

Status: Amber Xalacom eye drops

Specialist ophthalmologist recommendation

Status: Green Xylometazoline 0.1% nasal spray/drops

Short term use only

Building healthier lives
Back to top